Jeffrey John Mcdonald, | |
247 N Fireweed, Ste A, Soldotna, AK 99669-7593 | |
(907) 262-8597 | |
Not Available |
Full Name | Jeffrey John Mcdonald |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 32 Years |
Location | 247 N Fireweed, Soldotna, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821034869 | NPI | - | NPPES |
MD91351 | Medicaid | AK | |
P00064109 | Other | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 4800 (Alaska) | Primary |
207R00000X | Internal Medicine | 4800 (Alaska) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Central Peninsula General Hospital | Soldotna, AK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Alaska Hospitalist Group Llc | 6507755964 | 84 |
News Archive
A team of scientists has developed a computational method to map cancer progression, an advance that offers new insights into the factors that spur this affliction as well as new ways of selecting effective therapies.
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
This simple shift in how health care is paid for - long seen as key to taming costs - has been occurring in pockets of the country. But nowhere is it happening more systematically than in Massachusetts, the state that blazed a trail in 2006 by guaranteeing its residents health insurance. Now Massachusetts, a model for President Obama's 2010 national health care law, may offer another template for national leaders looking to control health spending.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and launch of the DF4 High-Voltage Connector System, a right ventricular lead and connector used with implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) to detect and accurately treat potentially life-threatening heart rhythms.
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke Medicine.
› Verified 7 days ago
Entity Name | Alaska Hospitalist Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831296995 PECOS PAC ID: 6507755964 Enrollment ID: O20040312001148 |
News Archive
A team of scientists has developed a computational method to map cancer progression, an advance that offers new insights into the factors that spur this affliction as well as new ways of selecting effective therapies.
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
This simple shift in how health care is paid for - long seen as key to taming costs - has been occurring in pockets of the country. But nowhere is it happening more systematically than in Massachusetts, the state that blazed a trail in 2006 by guaranteeing its residents health insurance. Now Massachusetts, a model for President Obama's 2010 national health care law, may offer another template for national leaders looking to control health spending.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and launch of the DF4 High-Voltage Connector System, a right ventricular lead and connector used with implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) to detect and accurately treat potentially life-threatening heart rhythms.
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke Medicine.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Jeffrey John Mcdonald, 247 N Fireweed, Sta A, Soldotna, AK 99669-7593 Ph: (907) 262-8597 | Jeffrey John Mcdonald, 247 N Fireweed, Ste A, Soldotna, AK 99669-7593 Ph: (907) 262-8597 |
News Archive
A team of scientists has developed a computational method to map cancer progression, an advance that offers new insights into the factors that spur this affliction as well as new ways of selecting effective therapies.
Nine out of 10 drugs successfully tested in mice and other animal models ultimately fail to work in people, and one reason may be traced back to a common fact of life for laboratory mice: they're cold, according to a researcher at the Stanford University School of Medicine.
This simple shift in how health care is paid for - long seen as key to taming costs - has been occurring in pockets of the country. But nowhere is it happening more systematically than in Massachusetts, the state that blazed a trail in 2006 by guaranteeing its residents health insurance. Now Massachusetts, a model for President Obama's 2010 national health care law, may offer another template for national leaders looking to control health spending.
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and launch of the DF4 High-Voltage Connector System, a right ventricular lead and connector used with implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) to detect and accurately treat potentially life-threatening heart rhythms.
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke Medicine.
› Verified 7 days ago